AEON Biopharma, Inc. AEON
Set alert
0.28 USD 0.00 +1.39%
As of Nov 2, 2:31 PM ET
0.27 Day range 0.2989
0.177 52-week range 1.45
- YTD
- -74.75%
- 1 year
- -67.32%
- Open
- 0.2768
- Prev close
- 0.274
- Mkt cap
- 16.41M
- Vol
- 280.32K
- Avg vol
- 7.55M
- EPS
- -4.39
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.27
- High
- 0.2989
- Forward P/E
- -0.84
- Beta
- 0.40
- Short ratio
- 1.60
- Inst. own
- 33.14%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 12, 2024
- 50-d avg
- 0.76512
- 200-d avg
- 2.58
- 1y target
- 5.00
MAX chart
Events in this range
- May 6, 2024Rating: HC Wainwright & Co. · Buy → Buy
- May 14, 2024Earnings: —; estimate -0.31; surprise —%
- May 14, 2024Earnings: -0.28; estimate -0.31; surprise 9.68%
- May 15, 2024Rating: HC Wainwright & Co. · Buy → Buy
- May 30, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Jul 10, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Aug 12, 2024Earnings: —; estimate -0.19; surprise —%
- Aug 12, 2024Earnings: -0.16; estimate -0.19; surprise 15.79%
- Aug 14, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Oct 1, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Nov 13, 2024Earnings: -0.16; estimate -0.16; surprise 0%
- Feb 26, 2025Split: 1 for 72
Signals (49)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Sep 7, 2026 | 1 month ago |
| RSI: Oversold | Aug 3, 2026 | 3 months ago |
| RSI: Oversold | Jul 13, 2026 | 3 months ago |
| SMA: Bearish | Apr 27, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Mar 30, 2026 | 7 months ago |
| SMA: Bullish | Mar 23, 2026 | 7 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| SMA: Bullish | Feb 16, 2026 | 8 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| SMA: Bullish | Dec 15, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 10 months ago |
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| SMA: Bearish | Nov 17, 2025 | 11 months ago |
| SMA: Bullish | Nov 3, 2025 | 12 months ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Sep 15, 2025 | 1 year ago |
| SMA: Bullish | Sep 8, 2025 | 1 year ago |
| SMA: Bearish | Aug 25, 2025 | 1 year ago |
| SMA: Bullish | Aug 18, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | May 19, 2025 | 1 year ago |
| SMA: Bearish | Oct 28, 2024 | 2 years ago |
| SMA: Bullish | Sep 30, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 5, 2024 | 2 years ago |
| SMA: Bearish | Jul 29, 2024 | 2 years ago |
| SMA: Bullish | Jul 15, 2024 | 2 years ago |
| SMA: Bearish | Apr 8, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 8, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| RSI: Overbought | Mar 11, 2024 | 2 years ago |
| RSI: Overbought | Feb 26, 2024 | 2 years ago |
| SMA: Bullish | Dec 25, 2023 | 2 years ago |
| SMA: Bullish | Nov 27, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 20, 2023 | 2 years ago |
| SMA: Bearish | Oct 23, 2023 | 3 years ago |
| MACD: Sell Signal | Oct 23, 2023 | 3 years ago |
| MACD: Buy Signal | Oct 9, 2023 | 3 years ago |
| SMA: Bullish | Oct 2, 2023 | 3 years ago |
| SMA: Bearish | Jul 24, 2023 | 3 years ago |
| SMA: Bullish | Jul 17, 2023 | 3 years ago |
| RSI: Oversold | Jun 12, 2023 | 3 years ago |
| SMA: Bearish | Jun 5, 2023 | 3 years ago |
| RSI: Overbought | May 8, 2023 | 3 years ago |
Financial health
Altman Z-Score
-129.27 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -0.3×
FY 2019 5y median -0.3× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B -0.2×
FY 2019 5y median -1.2× FY 2025
P/FCF -0.6×
FY 2019 5y median -5.6× FY 2025
EV/EBITDA -2.7×
FY 2019 5y median -5.0× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -158.6%
FY 2019 5y median -17.9% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE 71.3%
FY 2019 5y median 23.7% FY 2025
ROIC 1180.0%
FY 2019 5y median 1180.0% FY 2025
ROA -705.4%
FY 2019 5y median -705.4% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -117.5%
FY 2019 FY 2025
EPS (diluted) -105.4%
FY 2019 FY 2025
Free Cash Flow 14.7%
FY 2019 FY 2025
Financial Health
Current Ratio 0.5×
FY 2019 5y median 0.2× FY 2025
Quick Ratio 0.5×
FY 2019 5y median 0.2× FY 2025
Debt / Equity -0.6×
FY 2019 5y median -0.5× FY 2025
Net Debt / EBITDA -2.0×
FY 2019 5y median -2.0× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31